Miguel Angel Tejada
Overview
Explore the profile of Miguel Angel Tejada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lucarini E, Aguilera-Lizarraga J, Tejada M
Front Pharmacol
. 2025 Feb;
16:1546059.
PMID: 39944623
No abstract available.
2.
Huerta M, Marcos-Frutos D, Nava J, Garcia-Ramos A, Tejada M, Roza C
Eur J Pharmacol
. 2024 Oct;
984:177052.
PMID: 39393665
Background: P2X3 and P2X2/3 receptors are promising therapeutic targets for pain treatment and selective inhibitors are under evaluation in ongoing clinical trials. Here we aim to consolidate and quantitatively evaluate...
3.
Fell C, Hagelkruys A, Cicvaric A, Horrer M, Liu L, Shun Li J, et al.
EMBO Mol Med
. 2022 Aug;
14(9):e15829.
PMID: 35916241
Whole-exome sequencing of two patients with idiopathic complex neurodevelopmental disorder (NDD) identified biallelic variants of unknown significance within FIBCD1, encoding an endocytic acetyl group-binding transmembrane receptor with no known function...
4.
Nunez-Badinez P, De Leo B, Laux-Biehlmann A, Hoffmann A, Zollner T, Saunders P, et al.
Pain
. 2021 Aug;
162(9):2349-2365.
PMID: 34448751
Endometriosis (ENDO) and interstitial cystitis/bladder pain syndrome (IC/BPS) are chronic pain conditions for which better treatments are urgently needed. Development of new therapies with proven clinical benefit has been slow....
5.
Gonzalez-Cano R, Tejada M, Artacho-Cordon A, Nieto F, Entrena J, Wood J, et al.
Mar Drugs
. 2017 Jun;
15(6).
PMID: 28635651
Visceral pain is very common and represents a major unmet clinical need for which current pharmacological treatments are often insufficient. Tetrodotoxin (TTX) is a potent neurotoxin that exerts analgesic actions...
6.
Luna-Sanchez M, Diaz-Casado E, Barca E, Tejada M, Montilla-Garcia A, Cobos E, et al.
EMBO Mol Med
. 2015 Mar;
7(5):670-87.
PMID: 25802402
Primary coenzyme Q10 (CoQ10) deficiency is due to mutations in genes involved in CoQ biosynthesis. The disease has been associated with five major phenotypes, but a genotype-phenotype correlation is unclear....
7.
Nieto F, Cendan C, Sanchez-Fernandez C, Cobos E, Entrena J, Tejada M, et al.
J Pain
. 2012 Oct;
13(11):1107-21.
PMID: 23063344
Unlabelled: Sigma-1 (σ(1)) receptors play a role in different types of pain and in central sensitization mechanisms; however, it is unknown whether they are involved in chemotherapy-induced neuropathic pain. We...
8.
Nieto F, Cobos E, Tejada M, Sanchez-Fernandez C, Gonzalez-Cano R, Cendan C
Mar Drugs
. 2012 Mar;
10(2):281-305.
PMID: 22412801
Tetrodotoxin (TTX) is a potent neurotoxin that blocks voltage-gated sodium channels (VGSCs). VGSCs play a critical role in neuronal function under both physiological and pathological conditions. TTX has been extensively...